LGM Pharma RX
FDA Approved Drugs

LGM Pharma RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 15
  • Latest Approval Date May 28, 2021
  • Data Source FDA
  • First Approval Date Nov 30, 2001
All
16
View
Discontinued
1
View
RX
15
View
Company Overview

Company

LGM Pharma RX

Country

U.S.A

Website

Visit Website

Email

info@lgmpharma.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

LGM Pharma RX

6400 Congress Avenue, Suite 1400 Boca Raton, FL 33487

U.S.A

lgmpharma.com/ info@lgmpharma.com View on Map
FDA Approved Drug Records ( 15 records )
2011
23 Aug
RX Application: 90956

Drug Name

BUTALBITAL AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

300MG;50MG

Approval Date

2011-08-23

90956 / 1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL

Application Number

90956

Product Number

1

Dosage Form

-

Strength

300MG;50MG

Approval Date

2011-08-23

Regulatory Status

RX

2009
16 Nov
RX Application: 40885

Drug Name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Product Number

1

Dosage Form

-

Strength

300MG;50MG;40MG

Approval Date

2009-11-16

40885 / 1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Application Number

40885

Product Number

1

Dosage Form

-

Strength

300MG;50MG;40MG

Approval Date

2009-11-16

Regulatory Status

RX

2018
31 Oct
RX Application: 209587

Drug Name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2018-10-31

209587 / 1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Application Number

209587

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG

Approval Date

2018-10-31

Regulatory Status

RX

2004
10 Jun
RX Application: 76560

Drug Name

BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

2004-06-10

76560 / 1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Application Number

76560

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

2004-06-10

Regulatory Status

RX

2012
19 Jul
RX Application: 76560

Drug Name

BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE

Product Number

2

Dosage Form

-

Strength

300MG;50MG;40MG;30MG

Approval Date

2012-07-19

76560 / 2

Active Ingredient

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Application Number

76560

Product Number

2

Dosage Form

-

Strength

300MG;50MG;40MG;30MG

Approval Date

2012-07-19

Regulatory Status

RX

2001
30 Nov
RX Application: 75231

Drug Name

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

2001-11-30

75231 / 1

Active Ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Application Number

75231

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

2001-11-30

Regulatory Status

RX

2009
22 Oct
RX Application: 91019

Drug Name

CHENODIOL

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-10-22

91019 / 1

Active Ingredient

CHENODIOL

Application Number

91019

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-10-22

Regulatory Status

RX

2012
12 Mar
RX Application: 91522

Drug Name

GLYCOPYRROLATE

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2012-03-12

91522 / 1

Active Ingredient

GLYCOPYRROLATE

Application Number

91522

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2012-03-12

Regulatory Status

RX

2021
28 May
RX Application: 205479

Drug Name

HYDROCODONE BITARTRATE AND ASPIRIN

Product Number

1

Dosage Form

-

Strength

500MG;5MG

Approval Date

2021-05-28

205479 / 1

Active Ingredient

ASPIRIN; HYDROCODONE BITARTRATE

Application Number

205479

Product Number

1

Dosage Form

-

Strength

500MG;5MG

Approval Date

2021-05-28

Regulatory Status

RX

2013
19 Mar
RX Application: 204054

Drug Name

MECAMYLAMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2013-03-19

204054 / 1

Active Ingredient

MECAMYLAMINE HYDROCHLORIDE

Application Number

204054

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2013-03-19

Regulatory Status

RX

2019
30 Aug
RX Application: 203166

Drug Name

NABUMETONE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2019-08-30

203166 / 1

Active Ingredient

NABUMETONE

Application Number

203166

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2019-08-30

Regulatory Status

RX

2019
30 Aug
RX Application: 203166

Drug Name

NABUMETONE

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2019-08-30

203166 / 2

Active Ingredient

NABUMETONE

Application Number

203166

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2019-08-30

Regulatory Status

RX

2019
30 Aug
RX Application: 203166

Drug Name

NABUMETONE

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2019-08-30

203166 / 3

Active Ingredient

NABUMETONE

Application Number

203166

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2019-08-30

Regulatory Status

RX

2020
08 May
RX Application: 205789

Drug Name

URSODIOL

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2020-05-08

205789 / 1

Active Ingredient

URSODIOL

Application Number

205789

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2020-05-08

Regulatory Status

RX

2020
08 May
RX Application: 205789

Drug Name

URSODIOL

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2020-05-08

205789 / 2

Active Ingredient

URSODIOL

Application Number

205789

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2020-05-08

Regulatory Status

RX

Related Databases
  • FDA Inspections
    4 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    16 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
15 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BUTALBITAL AND ACETAMINOPHEN

Application Number

90956

Product Number

1

Active Ingredient

ACETAMINOPHEN; BUTALBITAL

Dosage Form

-

Strength

300MG;50MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit